Jeil Pharmaceutical Co Ltd Capital Reinvestment Ratio
Jeil Pharmaceutical Co Ltd capital reinvestment ratio. Jeil Pharmaceutical Co Ltd (271980) has a Capital Reinvestment Ratio of 4.20x as of December 2025, meaning it reinvests 4% of its operating cash flow (₩532.03 Million) in capital expenditures (₩2.23 Billion). Check total reinvestment intensity of Jeil Pharmaceutical Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Jeil Pharmaceutical Co Ltd (2018–2024)
Capital reinvestment ratio of Jeil Pharmaceutical Co Ltd from 2018 to 2024. This chart tracks Jeil Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 4 annual periods. Also explore Jeil Pharmaceutical Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Jeil Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (2018–2024)
Jeil Pharmaceutical Co Ltd capital reinvestment ratio by year from 2018 to 2024. For the full cash flow conversion analysis, see Jeil Pharmaceutical Co Ltd cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 2.06x | ₩3.21 Billion | ₩6.61 Billion | ▲ +635.6% |
| 2021 | 0.28x | ₩19.10 Billion | ₩5.34 Billion | ▲ +646.2% |
| 2019 | 0.04x | ₩28.96 Billion | ₩1.09 Billion | ▼ -92.2% |
| 2018 | 0.48x | ₩21.45 Billion | ₩10.29 Billion | — |